Fisher & Paykel Healthcare Corporation Limited logo

Initial Disclosure Notice – Neville Mitchell

Insider Disclosure13 November 2018FPHHealthcare

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Fisher & Paykel Healthcare

Corporation Limited

Date this disclosure made:

13-Nov-18

Date on which issuer listed or appointment made:

12-Nov-18

Director or senior manager giving disclosure

Full name:

Neville John Mitchell

Name of listed issuer:

Fisher & Paykel Healthcare

Corporation Limited

Name of related body corporate (if applicable):

Not Applicable

Position held in listed issuer:

Director

Summary of relevant interest (excluding specified derivatives)

Class of quoted financial product:

Ordinary Shares

Nature of relevant interest:

Beneficial

Number held in class:

7,200

Current registered holder:

N J Mitchell Superannuation Fund

Summary of specified derivatives relevant interest (if applicable)

Type of derivative:

Class of underlying financial products:

Details of derivative

The notional value of the derivative (if any) or the notional amount of

underlying products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price specified in the terms of the derivative(if any):

Any other details needed to understand how the amount of the

consideration payable under the derivative or the value of the derivative is

affected by the value of the underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature

of the relevant interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information

contained in this disclosure is correct and that I am duly authorised to make

this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:13-Nov-18

Name and title of authorised person:

Ed Timmins, General Counsel and

Company Secretary

Not Applicable

Not Applicable

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • FBU — Fletcher Building: D&O Initial Disclosure – Doug McKay
    2018-09-06

    Initial Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fletcher Building Limited Date this disclosure made:7 September 2018 Date of which…”

  • FBU — Fletcher Building: D&O Initial and Ongoing Disclosures – Multiple
    2018-09-30

    Initial Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fletcher Building Limited Date this disclosure made:28 September 2018 Date of which…”

  • FBU — Fletcher Building: D&O Ongoing Disclosures – Multiple
    2018-10-09

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fletcher Building Limited Date this disclosure made:10 October 2018 Date of last di…”